(Q66547083)
Statements
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD (English)
0 references
29 April 2016
0 references
30 March 2018
0 references
1,941
0 references
40 year
0 references
80 year
0 references